Skip to content

A prospective, multi-center, blinded, randomized, parallel controlled, non-inferiority clinical trial to evaluate the safety and effectiveness of bone adhesive for bone tissue adhesion and fixation

A prospective, multi-center, blinded, randomized, parallel controlled, non-inferiority clinical trial to evaluate the safety and effectiveness of bone adhesive for bone tissue adhesion and fixation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094518
Enrollment
Unknown
Registered
2024-12-24
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures of the limbs

Interventions

Sponsors

The Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) age >=18 years old and <=65 years old, both sexes; 2) for limb fractures caused by various reasons, fracture reduction and fixation should be performed; 3) one or two fractures located in different limb bones; 4) subjects or their legal representatives can understand the purpose of the study, demonstrate adequate compliance with the study protocol, and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) combined with systemic infection or uncontrolled local infection, severe soft tissue injury at the planned operation site, severe vascular or severe nerve injury, malignant tumor, or confirmed diagnosis 2) severe malnutrition or other vital organ failure; 3) weekly oral or injectable sedatives/hypnotics or non-steroidal anti-inflammatory drugs (except aspirin) during the 3 months before screening; 4) receiving chemotherapy or radiotherapy within 3 months before or during the screening period; 5) At least 14 days of oral corticosteroids or growth factor injections within 1 month before or during the screening period; 6) the limb to be operated on has osteofascial compartment syndrome; 7) pregnant or lactating women; 8) other situations where the investigator considers that the subject should not participate in the clinical trial for the benefit of the subject, etc.

Design outcomes

Primary

MeasureTime frame
Fracture healing rate 24 weeks after surgery;Instrument operation satisfaction assessment;

Secondary

MeasureTime frame
Fracture healing rate 12 weeks after surgery;Fracture healing time, etc;SF-36 scale score;Incidence of adverse events;Incidence of device defects;Use of fixation devices;Fracture reduction evaluation, etc;

Countries

China

Contacts

Public ContactYe Zhaoming

The Second Affiliated Hospital of Zhejiang University School of Medicine

yezhaominghz@163.com+86 571 8778 3567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026